Freenome, a year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of cancer, has landed $5.5 million in seed funding led by Andreessen Horowitz, with participation from Founders Fund, Data Collective, and Third Kind Venture Capital. The deal is a bit of a coup, coming as it does from Andreessen Horowitz’s months-old, $200 million Bio Fund. The vehicle, led… Read More...